Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder [NA]
A completed clinical trial compares two medical home models for the management of Attention Deficit/Hyperactivity Disorder.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [NA]
Update on a completed clinical trial evaluating behavioral treatment, pharmacologic treatment, and the combination of both for attention-def…
-
FDA approval · 2016-09-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for four amphetamine salt products (dextroamphetamine saccharate, amphetamine aspartate, dextro…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects
This clinical trials update reports the completion of a study evaluating the chronic effects of medications used to treat attention deficit …
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. [Phase 4]
Open-label Phase 4 trial evaluating naltrexone in adults with Attention Deficit Hyperactivity Disorder; results were posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
An update on a clinical trial assessing the effects of risperidone on cognitive function in adolescents with ADHD and behavioral disturbance…
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
A clinical trial investigating the effect of methylphenidate on primary enuresis in children with ADHD; the current trial status is unknown.
-
CLINICAL_TRIALS research · 2016-09-15Clinical Trial Update: Children With ADHD and ADHD-like Symptoms and Target Shooting Sport in Danish Shooting Associations. [NA]
A clinical trial update studying children with ADHD and ADHD-like symptoms, including participation in a target shooting sport within Danish…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Metabolic and Neurofunctional Responses to Breakfasts [NA]
This completed clinical trial evaluated metabolic and neurofunctional responses to breakfasts in individuals associated with feeding behavio…
-
FDA approval · 2016-08-26FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approves Cranbury Pharmaceuticals' dexmethylphenidate hydrochloride as an original-application generic product (for attention-deficit/hy…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD [Phase 4]
This document reports a 12-month open-label Phase 4 safety study of Aptensio XR in children aged 4-5 years diagnosed with attention-deficit/…
-
CLINICAL_TRIALS research · 2016-08-23Clinical Trial Update: The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder
A clinical trial update examining prepulse inhibition characteristics in children and adolescents with ADHD to better understand sensory pro…
-
FDA approval · 2016-08-22FDA Approved: GUANFACINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for guanfacine hydrochloride from Aurobindo Pharma Limited, authorizing changes to the approved …
-
FDA approval · 2016-08-19FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the methylphenidate transdermal system submitted by PADAGIS US LLC.
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: A Clinic-based Prevention Program for Families of Depressed Mothers [Phase 1]
Phase 1 completion reported for a clinic-based prevention program for families of depressed mothers; the study involves conditions including…
-
FDA approval · 2016-07-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's generic methylphenidate hydrochloride product under an Original Application. It is…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study [NA]
This entry reports the completion of a pilot clinical trial evaluating preference- and goal-directed attention in children with Attention De…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. [Phase 1]
A Phase 1 study assessing the safety, tolerability, and pharmacokinetics of multiple rising doses of TAK-137 in adults with attention-defici…
-
FDA approval · 2016-07-07FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc., resulting in an approved mod…
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach [NA]
Clinical trial update reporting completed MRI investigations in children with ADHD. The study aims to identify brain imaging differences tha…
-
CLINICAL_TRIALS research · 2016-06-24Clinical Trial Update: A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD) [NA]
A clinical trial sponsored by University Hospital Tuebingen evaluating biofeedback training for schoolchildren with attention-deficit/hypera…
-
FDA approval · 2016-06-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for methylphenidate hydrochloride (LA) from Dr. Reddy's Laboratories Inc.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. [Phase 3]
A completed Phase 3 study assessing whether Risperidone causes any cognitive or motor effects in youths with several behavioral and developm…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Assessing QbTest Utility in ADHD: A Randomised Controlled Trial [NA]
A completed randomized trial evaluating the utility of QbTest as a diagnostic/assessment tool in children with ADHD.
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Emotional and Non-emotional Regulation in Patients With Emotional Instability and ADHD [NA]
A Karolinska Institutet clinical trial evaluating emotional and non-emotional regulation in adults with Borderline Personality Disorder and …